[老年生理特征和营养状况中的微量营养素]
Ha Anh Tran1,2,3, Daniela Weber1,2, Tilman Grune4,5,6
1Abteilung Molekulare Toxikologie, Deutsches Institut für Ernährungsforschung Potsdam-Rehbrücke (DIfE), Arthur-Scheunert-Allee 114-116, 14558, Nuthetal, Deutschland.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz
|October 13, 2025
概括
衰老涉及到导致功能衰退和疾病风险的细胞变化. 确保足够的微量营养素摄入,如维生素D和B12,对于健康的衰老和预防缺陷至关重要.
科学领域:
- 老年学是一门学科.
- 营养科学 营养科学
- 分子生物学分子生物学
背景情况:
- 衰老是一个复杂的生物过程,其特点是各个器官系统的分子和细胞变化.
- 这些变化导致生理功能下降,并增加对骨质疏松症和阿尔茨海默病等与年龄有关的疾病的易感性.
- 健康的生活方式,特别是富含微量营养素的均衡饮食,对于缓解与年龄相关的衰退至关重要.
研究的目的:
- 提供衰老生理特征的概述.
- 解决老年人中微量营养素供应的关键作用.
- 突出特定微量营养素对健康衰老的重要性.
主要方法:
- 关于生理衰老过程的文献综述.
- 对老年人群中微量营养素需求的分析.
- 讨论微量营养素缺乏对衰老的影响.
主要成果:
- 关键的微量营养素如维生素D,维生素B12,,铁,叶酸和对于老年人来说至关重要.
- 这些微量营养素对免疫功能,骨代谢,细胞过程和能量生产至关重要.
- 微量营养素缺乏可以加速衰老过程并增加疾病风险.
结论:
- 适当的微量营养素摄入对于老年人健康老龄化和疾病预防至关重要.
- 健康的老年人应遵守微量营养素的已确定的饮食参考值 (例如,DGE).
- 患有特定疾病的老年人应遵循特定疾病的指导方针,以确保足够的微量营养素状态.
更多相关视频
相关概念视频
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
232
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
232
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
234
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
234
Pharmacodynamics in Geriatric Patients: Effects of Age
187
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
187
Drug Dosing: Geriatric Patients
225
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
225
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
227
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
227
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
196
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
196


